OakChart

CorMedix Inc

CRMDHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

5.30-0.07 (-1.30%)
2026-11-12 05:40 CET
Market cap
413.10 USD m
Revenue, TTM
462.25 USD m
Net income, TTM
187.17 USD m
Free cash flow, TTM
250.11 USD m
EPS diluted, TTM
2.10
P/E
2.52
Compare

Price

CRMD against its 20, 50 and 200-day averages
2050200beatearnings
6.008.0010.003.5M7.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CRMDclose 5.3020-day 6.7150-day 7.33200-day 7.605.30

59.3% under the 52-week high of 13.02 on 30 Dec 2025. 52-week low 5.10 on 6 Nov 2026. Last 15 sessions, 63.8% high to low

Volume 1.18× normal · the line is the 50-bar volume average

Profile

CRMD
52-week range, 3% of the way up
5.1013.02

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

IndexRUT
Employees191
IPOMay 13, 2010
Beta1.49
ATR, 14d0.40
Rel volume1.18
Short float19.87%
Insider own8.29%
Inst own55.48%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap413.10M
Enterprise Value300.90M
Income187.17M
Sales462.25M
Book/sh5.93
Cash/sh3.30
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees191
IPOMay 13, 2010

Ratios

P/E2.52
Forward P/E69.74
PEG-
P/S0.89
P/B0.89
P/C1.61
P/FCF1.65
EV/EBITDA1.19
EV/Sales0.65
Quick Ratio2.36
Current Ratio2.56
Debt/Eq0.31
LT Debt/Eq0.31
Option/ShortYes / Yes

Earnings

EPS (ttm)2.10
EPS next Y0.08
EPS next Q-0.12
EPS this Y-76.86%
EPS next Y-83.90%
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y1582.83% 319.75%
EPS Y/Y TTM210.82%
Sales Y/Y TTM280.50%
EPS Q/Q1.92%
Sales Q/Q156.52%
EarningsNov 12 BMO
EPS/Sales Surpr.21.85% 6.13%

Ownership

Insider Own8.29%
Insider Trans0.00%
Inst Own55.48%
Inst Trans2.79%
ROA32.36%
ROE54.93%
ROIC30.89%
Gross Margin82.78%
Oper. Margin46.95%
Profit Margin40.49%
SMA20-21.00%
SMA50-27.70%
SMA200-30.24%
Trades-

Technical

Shs Outstand77.67M
Shs Float71.48M
Short Float19.87%
Short Ratio10.27
Short Interest14.21M
52W High13.02 -59.29%
52W Low5.10 3.92%
Volatility6.76% 6.79%
ATR (14)0.40
RSI (14)28.78
Beta1.49
Rel Volume1.18
Avg Volume1.38M
Volume1,625,909

Performance

Perf Week-6.36%
Perf Month-28.28%
Perf Quarter-34.89%
Perf Half Y-29.33%
Perf YTD-54.43%
Perf Year-52.64%
Perf 3Y64.60%
Perf 5Y0.38%
Perf 10Y-42.39%
Recom1.00
Target Price15.20
Prev Close5.37
Price5.30
Change %-1.30%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 23, 2026InitiatedOOppenheimerOutperform$15+183.0%
Oct 20, 2025UpgradeDD. Boral CapitalHold → Buy$14+164.2%
Jun 30, 2025InitiatedHH.C. WainwrightBuy$20+277.4%
Jun 30, 2025DowngradeDD. Boral CapitalBuy → Hold
Mar 07, 2025InitiatedLLeerink PartnersOutperform$18+239.6%
Jan 13, 2025InitiatedDD. Boral CapitalBuy$15+183.0%
Aug 26, 2024InitiatedRRodman & RenshawBuy$13+145.3%
Aug 10, 2023InitiatedRRBC Capital MktsOutperform$6+13.2%
Feb 17, 2021InitiatedNNeedhamBuy$31+484.9%
Sep 29, 2020InitiatedJJMP SecuritiesMkt Outperform$22+315.1%

Peers

Mkt cap
TickerCompanyMkt cap
ARDXArdelyx Inc786.79M
CTXRCitius Pharmaceuticals Inc13.20M
SPROSpero Therapeutics Inc59.40M
PYPDPolypid Ltd134.06M
UNCYUnicycive Therapeutics Inc105.29M
HRTXHeron Therapeutics Inc68.36M
PHATPhathom Pharmaceuticals Inc510.51M
PCRXPacira BioSciences Inc1.46B
PLXProtalix BioTherapeutics Inc252.18M
ICUSeaStar Medical Holding Corp10.21M

Insider trading

latest 14 of 22
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Dillione JanetDirectorJan 21 '26Sale6.8810,00068,80038,473Jan 22 09:30 PM
Janet DillioneDirectorJan 21 '26Proposed Sale6.8510,00068,502Jan 21 04:42 PM
Todisco JosephChief Executive OfficerJan 16 '26Option Exercise3.3829,58599,997521,664Jan 20 09:28 AM
Lefkowitz Steven WDirectorJan 12 '26Option Exercise5.6315,00084,45095,498Jan 14 09:30 PM
DUNTON ALAN WDirectorDec 30 '25Option Exercise4.0320,00080,60060,250Jan 02 09:30 PM
DUNTON ALAN WDirectorDec 30 '25Sale13.0020,000260,00040,250Jan 02 09:30 PM
Alan DuntonDirectorDec 30 '25Proposed Sale12.9720,000259,400Dec 30 04:28 PM
Todisco JosephChief Executive OfficerDec 18 '25Option Exercise4.4330,000132,900539,496Dec 19 09:30 PM
Todisco JosephChief Executive OfficerDec 18 '25Sale12.0030,000360,000509,496Dec 19 09:30 PM
Joseph TodiscoOfficerDec 18 '25Proposed Sale11.9730,000359,149Dec 18 04:35 PM
Dillione JanetDirectorDec 09 '25Option Exercise7.8234,000265,90082,473Dec 11 08:38 AM
Dillione JanetDirectorDec 09 '25Sale12.0034,000408,00048,473Dec 11 08:38 AM
Lefkowitz Steven WDirectorDec 09 '25Sale11.8840,000475,20080,498Dec 10 09:38 PM
Janet DillioneBODDec 09 '25Proposed Sale12.0034,000408,000Dec 09 04:43 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
XPHState Street SPDR S&P Pharmaceuticals ETFAUM: 516.35M
IWNiShares Russell 2000 Value ETFAUM: 14.10B
CALFPacer US Small Cap Cash Cows ETFAUM: 3.86B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.120--51.765
2026Q22026-08-130.2900.2381.260101.9396.045
2026Q12026-05-140.4300.3430.415127.4104.967
2025Q42026-03-050.1600.8160.149128.62127.027
2025Q32025-11-121.2600.6341.259104.386.027
2025Q22025-08-070.2900.1870.27639.7435.087
2025Q12025-05-060.3000.2600.29939.0836.956
2024Q42025-03-250.2200.1320.21931.2127.286
2024Q32024-10-30-0.050-0.122-0.04711.4610.355
2024Q22024-08-14-0.250-0.251-0.2460.811.674
2024Q12024-05-09-0.250-0.277-0.2520.000.004
2023Q42024-03-12-0.260-0.201-0.2570.00-0.334
2023Q32023-11-14-0.170-0.210-0.1720.000.004
2023Q22023-08-08-0.250-0.239-0.2490.000.003
2023Q12023-05-15-0.240-0.201-0.2400.000.003
2022Q42023-03-30-0.200-0.187-0.1960.030.003

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.800-1.275-1.7870.280.35
2020FY-0.770-0.820-0.7710.240.21
2021FY-0.750-0.797-0.7490.190.12
2022FY-0.740-0.731-0.7380.070.03
2023FY-0.910-0.850-0.9100.00-0.33
2024FY-0.300-0.384-0.30543.4740.09
2025FY2.0402.6812.250311.71310.12
2026FY-0.472--334.88
2027FY-0.076--331.31
2028FY-0.420--412.53
2029FY-0.927--499.15
2030FY-1.347--570.69

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-0650251.7650.8553.90
2026Q3S2026-10-3060252.7750.8557.80
2026Q3S2026-10-2860152.9050.8557.80
2026Q3S2026-10-2760053.2350.8557.80
2026Q3S2026-10-1661253.2350.8557.80
2026Q3S2026-09-2261253.2350.8557.80
2026Q3S2026-08-1351253.2750.8557.80
2026Q3S2026-07-2850053.9653.0055.30
2026Q3S2026-07-0653253.9653.0055.30
2026Q3S2026-06-1153253.9452.8855.30
2026Q3S2026-05-2163353.8452.8855.30
2026Q3S2026-05-1473455.8752.8868.00
2026Q3S2026-04-1672253.6840.8072.00
2026Q3S2026-04-1472253.7840.8072.00

Estimate history

EPS, annual-3-1.506-1.787-0.771-0.749-0.738-0.91-0.3052.032.1046
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.246-0.0470.2190.2990.2761.2590.1490.4150.281
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.3290.430.2830.2390.1910.065043.472311.709462.25
Period201720182019202020212022202320242025TTM
Sales, quarterly0.80611.45631.2139.08239.737104.275128.615127.427101.931
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual14.28321.77525.66533.55838.08642.81554.93864.41179.26177.667
Period201720182019202020212022202320242025MRQ
Shares, quarterly55.27557.88764.41167.71174.62178.34979.26178.39577.667
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue462.25311.7143.470.000.070.190.240.280.43
Cost of Goods Sold Incl. D&A79.6135.963.190.210.210.210.350.450.47
Gross Profit382.64275.7540.28-0.21-0.15-0.02-0.11-0.16-0.04
Selling, General and Administrative Excl. Other165.60125.6162.6448.7530.4829.4227.1120.8426.82
Research and Development27.5919.333.9413.1610.6813.1313.3811.0518.82
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income217.04150.14-22.36-48.96-30.62-29.44-27.22-21.01-26.86
Interest Expense-2.780.040.000.030.020.030.790.00
Unusual Expense12.991.140.000.000.000.000.000.000.00
Net Income Before Taxes203.40150.02-19.32-46.34-30.29-29.46-27.20-21.49-26.83
Income Taxes16.23-13.04-1.390.00-0.59-1.25-5.17-5.060.00
Consolidated Net Income187.17163.06-17.93-46.34-29.70-28.21-22.03-16.43-26.83
Net Income From Continuing Operations187.17163.06-17.93-46.34-29.70-28.21-22.03-16.43-26.83
Net Income187.17163.06-17.93-46.34-29.70-28.21-22.03-43.17-26.83
EPS (Recurring)2.122.04-0.30-0.91-0.74-0.75-0.77-1.79-1.51
EPS (Basic, Before Extraordinaries)2.422.26-0.30-0.91-0.74-0.75-0.77-1.79-1.51
EPS (Diluted)2.102.03-0.30-0.91-0.74-0.75-0.77-1.79-1.51
EBITDA252.53165.13-21.90-48.75-30.41-29.26-27.08-20.93-26.79
Non-Operating Income (Expense)2.113.793.072.620.36-0.010.060.300.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense12.8910.934.845.493.213.681.821.781.11
Price To Earnings Ratio2.522.52-------
Price To Sales Ratio1.573.0010.97-2,598.42897.58887.07620.71267.38
Gross Margin82.7888.4692.66--225.30-10.42-45.61-57.63-9.59
Operating Margin46.9548.17-51.43--46,819.91-15,417.51-11,378.44-7,416.31-6,250.44
Net Margin40.4952.31-41.24--45,409.90-14,774.70-9,207.70-15,238.74-6,242.40
Shares Outstanding77.6779.2664.4154.9442.8238.0933.5625.6721.78
Market Capitalization413.10413.10491.49206.09174.21173.29238.74186.75140.45

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue101.93127.43128.62104.2839.7439.0831.2111.46
Cost of Goods Sold Incl. D&A24.8022.3021.3111.191.861.601.180.69
Gross Profit77.13105.12107.3193.0837.8737.4830.0310.77
Selling, General and Administrative Excl. Other34.2241.4648.1841.7318.3317.3617.1014.06
Research and Development6.687.218.605.102.443.191.730.73
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income42.9163.6659.1351.3519.5420.1312.94-3.29
Interest Expense--1.820.950.010.010.010.01
Unusual Expense4.117.751.83-0.690.000.000.000.00
Net Income Before Taxes38.7355.6556.4552.5820.3520.6413.46-2.78
Income Taxes12.7417.0442.43-55.990.520.000.000.00
Consolidated Net Income25.9938.6014.02108.5619.8320.6413.46-2.78
Net Income From Continuing Operations25.9938.6014.02108.5619.8320.6413.46-2.78
Net Income25.9938.6014.02108.5619.8320.6413.46-2.78
EPS (Recurring)0.310.470.161.250.280.300.22-0.05
EPS (Basic, Before Extraordinaries)0.330.490.181.430.290.320.22-0.05
EPS (Diluted)0.280.420.151.260.280.300.22-0.05
EBITDA53.4574.2069.7455.1419.7120.2913.11-3.17
Non-Operating Income (Expense)-0.07-0.270.961.490.810.530.540.52
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.233.622.843.212.112.771.190.97
Price To Earnings Ratio2.523.425.6615.5854.66---
Price To Sales Ratio1.571.583.504.687.295.1511.4638.76
Gross Margin75.6682.5083.4389.2695.3195.9196.2394.01
Operating Margin42.1049.9645.9749.2449.1851.5041.45-28.70
Net Margin25.5030.2910.90104.1149.9052.8243.14-24.24
Shares Outstanding77.6778.4079.2678.3574.6267.7164.4157.89
Market Capitalization413.10536.75916.32907.82835.60401.52491.49451.35

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments149.1951.6976.1158.9265.6046.5428.5117.8012.16
Short Term Receivables171.2351.650.000.000.050.000.000.010.06
Inventories29.727.602.110.000.000.140.340.430.59
Other Current Assets16.913.631.240.630.821.490.500.430.45
Total Current Assets367.05114.5879.4559.5566.4748.1829.3518.6713.27
Net Property, Plant & Equipment9.932.322.512.382.371.130.130.160.19
Total Investments and Advances10.700.110.100.100.100.000.000.000.00
Intangible Assets409.071.840.000.000.000.000.000.000.00
Deferred Tax Assets67.76--------
Other Assets13.120.000.000.000.000.000.000.000.00
Total Assets877.63118.8582.0662.0468.9549.3129.4818.8313.45
Short Term Debt Incl. Current Port. of LT Debt1.450.170.150.130.120.110.000.000.00
Accounts Payable7.881.724.282.202.211.131.022.591.81
Income Tax Payable12.76--------
Other Current Liabilities152.1831.956.973.973.012.924.805.184.45
Total Current Liabilities174.2733.8411.406.315.354.165.837.776.26
Long Term Debt147.470.350.520.670.800.920.006.130.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities51.49--------
Other Liabilities99.100.000.000.000.000.000.000.000.00
Total Liabilities472.3234.1911.926.986.155.095.8313.896.26
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity405.3184.6670.1455.0662.8044.2223.654.937.19
Total Shareholders Equity405.3184.6670.1455.0662.8044.2223.654.937.19
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity405.3184.6670.1455.0662.8044.2223.654.937.19
Total Liabilities & Stockholders Equity877.63118.8582.0662.0468.9549.3129.4818.8313.45
Book Value Per Share5.111.311.281.291.651.320.920.230.50
Tangible Book Value Per Share-0.051.291.281.291.651.320.920.230.50
Full-Time Employees1916582413035302214
Price to Book Ratio0.897.992.483.092.765.647.9028.473.22
Return on Assets32.73-17.85-64.32-45.35-47.71-55.92-68.04-166.23-186.71
Return on Equity66.56-23.17-74.02-50.40-52.72-64.91-114.99-442.46-264.00
Return on Invested Capital29.50-21.09-65.58-53.30-44.36-48.79-69.49-242.59-458.89
Quick Ratio1.943.166.789.4412.4311.544.982.352.02
Current Ratio2.113.396.979.4412.4411.585.042.402.12

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income187.17163.06-17.93-46.34-29.70-28.21-22.03-16.43-26.83
Depreciation35.7514.990.460.210.210.180.140.070.07
Other Funds (Non Cash)30.8815.536.275.494.075.042.543.011.11
Funds from Operations244.94167.78-11.21-40.64-25.42-22.99-19.34-13.34-25.64
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital8.687.27-39.412.231.071.84-2.63-1.931.94
Cash from Operating Activities253.62175.05-50.61-38.41-24.36-21.16-21.97-15.28-23.70
Capital Expenditures-3.52-2.26-0.12-0.33-0.22-1.43-0.11-0.04-0.05
Net Assets From Acquisitions-308.51-308.510.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments26.412.3421.35-16.73-3.49-7.717.54-11.981.60
Purchase of Investments-14.68-52.95-26.77-77.08-31.14-15.29-8.55-14.110.00
Sale Or Maturity of Investments41.0955.2948.1260.3527.657.5816.092.121.60
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-285.62-308.4321.23-17.06-3.71-9.137.43-12.021.56
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-10.1296.5526.6156.1217.9041.7640.1024.0322.01
Repurchase of Common Pref Stock-17.480.000.000.000.000.000.000.000.00
Sale of Common Pref Stock7.3696.5526.6156.1217.9041.7640.1024.0322.01
Proceedsfrom Stock Options1.0390.1618.8855.8317.7741.4639.6915.2321.97
Issuance or Reduction of Debt, Net144.08144.080.000.000.000.000.000.007.39
Change in Long Term Debt144.08144.080.000.000.000.000.000.007.39
Issuance of Long Term Debt150.00150.000.000.000.000.000.000.007.39
Reduction of Long Term Debt-5.92-5.920.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-3.70-2.18-0.29-0.200.000.000.002.000.00
Other Financing Activities Uses-3.70-2.18-0.29-0.200.000.000.000.000.00
Cash from Financing Activities130.26238.4526.3255.9217.9041.7640.1026.0329.40
Exchange Rate Effect-0.000.00-0.000.00-0.01-0.010.01-0.00-0.01
Net Change in Cash98.27105.07-3.070.45-10.1811.4525.57-1.277.24
Free Cash Flow250.11172.79-50.73-38.74-24.58-22.58-22.08-15.32-23.75
Preferred Dividends (Cash Flow)-0.00-------
Price to Free Cash Flow2.905.41-------
Deferred Taxes & Investment Tax Credit--25.800.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments257.35178.74149.1955.72190.7177.50
Short Term Receivables161.31154.81171.23158.5742.9154.61
Inventories38.5830.7329.7228.929.637.49
Other Current Assets23.3218.8316.9116.334.805.26
Total Current Assets480.55383.11367.05259.54248.06144.86
Net Property, Plant & Equipment7.856.179.938.392.052.18
Total Investments and Advances0.330.3310.700.990.110.11
Intangible Assets388.47398.77409.07407.531.741.79
Deferred Tax Assets0.003.3167.7652.50--
Other Assets26.8423.9413.1221.930.640.64
Total Assets904.05815.64877.63750.86252.60149.58
Short Term Debt Incl. Current Port. of LT Debt0.000.001.451.420.180.17
Accounts Payable10.2412.837.8820.455.821.93
Income Tax Payable13.0516.8412.764.22--
Other Current Liabilities164.1099.11152.18107.5425.7232.28
Total Current Liabilities187.40128.78174.27133.6431.7134.39
Long Term Debt145.15144.88147.472.970.260.30
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.66-51.49144.53--
Other Liabilities110.01104.9399.1095.590.000.00
Total Liabilities443.22378.59472.32376.7331.9734.69
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity460.83437.05405.31374.13220.63114.89
Total Shareholders Equity460.83437.05405.31374.13220.63114.89
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity460.83437.05405.31374.13220.63114.89
Total Liabilities & Stockholders Equity904.05815.64877.63750.86252.60149.58
Book Value Per Share5.935.575.114.782.961.70
Tangible Book Value Per Share0.930.49-0.05-0.432.931.67
Full-Time Employees--191---
Price to Book Ratio0.891.332.443.937.264.69
Return on Assets32.3637.5132.7339.2332.9715.79
Return on Equity54.9365.5966.5675.0838.3519.87
Return on Invested Capital4.296.632.5428.798.9817.92
Quick Ratio2.362.741.941.737.523.99
Current Ratio2.562.982.111.947.824.21

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income25.9938.6014.02108.5619.8320.64
Depreciation10.5410.5410.873.790.160.16
Other Funds (Non Cash)8.7412.865.443.842.713.55
Funds from Operations49.2474.9764.2256.5122.7024.35
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital36.81-32.7330.24-25.657.29-4.62
Cash from Operating Activities86.0642.2594.4630.8629.9919.74
Capital Expenditures-0.56-0.73-1.72-0.51-0.02-0.01
Net Assets From Acquisitions0.000.001.49-310.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.003.693.5319.19-20.19-0.18
Purchase of Investments0.000.00-0.07-14.61-28.29-9.98
Sale Or Maturity of Investments0.003.693.6033.798.109.80
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.562.963.30-291.32-20.21-0.19
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.00--
Change in Capital Stock-6.16-9.914.621.3383.497.11
Repurchase of Common Pref Stock-6.39-11.090.000.000.000.00
Sale of Common Pref Stock0.231.184.621.3383.497.11
Proceedsfrom Stock Options0.000.001.030.0082.376.76
Issuance or Reduction of Debt, Net0.000.00-5.59149.670.000.00
Change in Long Term Debt0.000.00-5.59149.670.000.00
Issuance of Long Term Debt0.000.000.00150.000.000.00
Reduction of Long Term Debt0.000.00-5.59-0.330.000.00
Net Financing Active Other Cash Flow-0.74-2.05-0.45-0.46-0.25-1.02
Other Financing Activities Uses-0.74-2.05-0.45-0.46-0.25-1.02
Cash from Financing Activities-6.89-11.96-1.41150.5383.246.09
Exchange Rate Effect0.000.00-0.000.000.000.00
Net Change in Cash78.6133.2596.34-109.9393.0225.63
Free Cash Flow85.5041.5292.7430.3529.9719.73
Price to Free Cash Flow2.903.246.3213.4729.14-

Revenue breakdown

Contract2025: 7.37M
Defen Cath2025: 258.81M
Melinta Portfolio2025: 45.53M
Product2024: 43.47M
United States2024: 43.47M 2025: 311.71M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3019.87%14.2M71.5M1.22M
2026-10-1520.52%14.7M71.5M1.10M
2026-09-3021.58%15.4M71.5M1.06M
2026-09-1522.67%16.2M71.5M1.24M
2026-08-3122.40%16.0M71.6M1.30M
2026-08-1423.89%17.1M71.8M1.34M
2026-07-3122.53%16.3M72.3M1.30M
2026-07-1521.24%15.3M72.3M1.31M
2026-06-3020.66%14.9M72.3M1.32M
2026-06-1520.08%14.5M72.2M1.23M
2026-05-2920.13%14.6M72.3M1.35M
2026-05-1521.73%15.5M71.5M1.34M
2026-04-3023.03%16.2M70.4M1.41M
2026-04-1522.14%15.7M71.0M1.69M
2026-03-3122.29%15.8M70.8M2.47M
2026-03-1322.38%15.8M70.8M2.68M
2026-02-2723.47%16.6M70.8M2.82M
2026-02-1323.94%16.9M70.6M3.08M
2026-01-3023.79%16.3M68.7M3.32M
2026-01-1525.82%17.9M69.3M3.34M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.002.256.500.000.0000.000.000.983-0.0130.000
call2.001.905.400.0035.2980.000.000.969-0.0130.001
call3.001.003.202.307.7010.001.000.926-0.0200.001
call4.000.003.603.949.5002.000.000.878-0.0170.002
call5.000.550.750.561.83829236.000.636-0.0460.003
call6.000.150.200.201.3386251,7230.313-0.0220.003
call7.000.001.100.051.31494.0038.000.105-0.0110.001
call8.000.002.150.031.74686120.000.084-0.0130.001
call9.000.000.450.512.1021,1370.000.073-0.0140.001
call10.000.000.050.052.2432,0400.000.066-0.0130.001
call11.000.002.150.152.6722.000.000.061-0.0150.001
call12.000.000.200.102.7216.000.000.057-0.0140.001
call13.000.002.150.003.1200.000.000.054-0.0160.001
call14.000.000.500.003.3130.000.000.052-0.0160.001
call15.000.002.150.003.4890.000.000.050-0.0170.001
call16.000.002.150.003.6510.000.000.049-0.0170.001
put1.000.000.050.006.6600.000.00-0.017-0.0130.000
put2.000.000.050.004.7400.000.00-0.045-0.0210.001
put3.000.002.150.003.0170.000.00-0.074-0.0200.001
put4.000.000.100.004.5640.000.00-0.228-0.0630.003
put5.000.100.750.242.8226710.00-0.364-0.0450.003
put6.000.650.900.851.3582160.00-0.687-0.0220.003
put7.001.651.851.801.8563,3622.00-0.895-0.0100.001
put8.001.653.402.584.33678.000.00-0.916-0.0120.001
put9.002.804.403.304.1711.000.00-0.927-0.0130.001
put10.002.556.802.439.5890.000.00-0.934-0.0130.001
put11.003.507.803.439.9530.000.00-0.939-0.0140.001
put12.004.508.803.5010.2760.000.00-0.943-0.0140.001
put13.005.509.804.4510.5640.000.00-0.946-0.0150.001
put14.006.5010.805.6010.8251.000.00-0.948-0.0150.001
put15.007.5011.807.4311.0632.000.00-0.950-0.0150.001
put16.008.5012.800.0011.2810.000.00-0.951-0.0150.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-108-KCurrent report2026-11-09SEC
2026-11-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-098-KCurrent report2026-11-08SEC
2026-11-028-KCurrent report2026-11-02SEC
2026-10-198-KCurrent report2026-10-19SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-18SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-29SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-29SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-29SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-078-KCurrent report2026-08-07SEC
2026-07-028-KCurrent report2026-06-29SEC
2026-07-018-KCurrent report2026-06-25SEC
2026-06-25S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-06-248-KCurrent report2026-06-23SEC
2026-06-12SCHEDULE 13G/ASEC
2026-06-12SCHEDULE 13G/ASEC
2026-06-088-KCurrent report2026-06-08SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-148-KCurrent report2026-05-14SEC
2026-04-29ARSAnnual report to security holders. 2025-12-31SEC
2026-04-29DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-23SEC
2026-04-278-KCurrent report2026-04-27SEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-068-KCurrent report2026-03-06SEC
2026-03-0510-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010068.80K1
2025-12001.97M5
2025-1100604.19K2

Institutional holders

Manager% owned
BlackRock, Inc.8.06%
Deep Track Capital, LP8.00%
VANGUARD CAPITAL MANAGEMENT LLC4.00%
STATE STREET CORP2.95%
UBS Group AG2.89%
GEODE CAPITAL MANAGEMENT, LLC2.45%
ROYCE & ASSOCIATES LP2.13%
OBERWEIS ASSET MANAGEMENT INC/1.69%
Alyeska Investment Group, L.P.1.08%
MARSHALL WACE, LLP0.99%

Funds

Fund% owned
AQR Diversified Arbitrage Fund3.38%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.84%
iShares Russell 2000 ETF2.47%
Avantis U.S. Small Cap Value ETF1.95%
Oberweis Micro-Cap Fund1.63%
VANGUARD EXTENDED MARKET INDEX FUND1.05%
Fidelity Small Cap Index Fund1.04%
iShares Russell 2000 Value ETF0.87%
Pacer US Small Cap Cash Cows 100 ETF0.80%
Royce Small-Cap Opportunity Fund0.72%

OakChart. CRMD. Cached 15 minutes.